The study evaluates trends in transfusion rates for major abdominal oncologic resections to assess changes in recent clinical practice (given the accumulating evidence of the deleterious effects of blood transfusion).
This randomized clinical trial reports that in patients with a body mass index of 50 to 60 kg/m2, duodenal switch resulted in greater weight loss and greater improvements in low-density lipoprotein cholesterol, triglycerides, and glucose 5 years after surgery compared with gastric bypass while improvements in health-related quality of life were similar.
This retrospective review of data indicates that the survival outcome in patients undergoing surgery for gastric cancer is associated with lymph node count rather than with cancer program classification.
Brar et al define optimal treatment strategies for gastric adenocarcinoma. See also the invited commentary by Schulick.